Ka lāʻau 'Phosphogliv'. 'Āpana alakaʻi medicament

I kēia lā o ka honua, he ākea ake maʻi. E like me ke kino e hanaʻia ka walaʻauʻana hana o detoxification i loko o ke kino, ke ake koi ke akahele e pili ana (keia ua maopopo loa i kekahi kauka). Ia mea no ia kumu, ua hoi he kūikawā pūʻulu o pharmaceuticals - gepatoprotektory.

Ka lāʻau "Phosphogliv" a ianoiyuaa a me ka 'inikua hoʻomaʻamaʻa Ua laha. ma o ka hana o keia k alakai he maʻamau 'ike (nāʻikepili, contraindications, adverse reactions, e like me ka' ike e pili ana i nā hiʻona farmadinamiki a me ka pharmacokinetics).

Ka papa kuhikuhi o ka hana o ka mea lāʻau lapaʻau lāʻau - ake hoomalu. Penei, pharmacological Agena "Phosphogliv", olelo ao no ka hana i wehewehe i au mamuli o kaʻano papa hana o ka hana o ka lāʻau ma luna o ke kino o ke kanaka, he hepatoprotector.

Ma waho aʻeo i kona papa manao, i ka lāʻau, he potent antiviral haʻawina, e like me ka hookupaa iho la ia ma ka ikea ai. E like me ka ke keʻena o ka halepaahao membranes, kaʻeleu 'Oponopono (phosphatidylcholine) ka poʻea pau i ka hoihoi hou ana a me ka hoʻoikaika' ana i o ke akepaʻa aeea hale. Ka hope e hōʻoiaʻiʻo i ka loaa ana o ka poino akepaʻa (maʻamau hoʻololi kemikala o nā'ūhū a normalize hoonohonoho hou macronutrients). Part o ka paʻakai glycyrrhizinate lāʻau hiki aku ai i ka suppression o ka mea hoʻomaʻi replication ma ke akepaʻa keena. Keia mea aie a hiki i ka stimulation o interferon-i? Iecaianoaaiiuo, ka hōʻoi 'phagocytosis haʻawina, a me ka ho'ā hope o maoli kai keena.

Ua mea waiwai 'ana i kumumanaʻo ana i ka hoʻohana' ana i ka lāʻau me ka nui loa ho'ēmi i kā ka pilikia o ka ulu cirrhosis a me fibrosis o ke akepaʻa'aʻaʻa.

Ma waho aʻeo ia ka luna hoomalolo, aia no he kūikawā palapala - lapaau "Phosphogliv forte." Na Ke Kumu no ka hoʻohana ana i ka lāʻau hoomalolo mea analogous i na kuhikuhi i ho'ākāka 'ia ma luna. A kiʻiona hiʻona o ka hooloihi ae i hopena o ka hope.

Nāʻikepili no ka lāʻau inoa:

- hepatitis (huʻi paha maʻi ano);

- degenerative maʻi o ke akepaa (steatosis, cirrhosis, mimikō, tuberculosis);

- ake eha lāʻau a me ka waiʻona etiology;

- huʻi a me ka maʻi ake ole;

- likeʻole intoxication;

- likeʻole ili maʻi (psoriasis, eczema, atopic dermatitis, neurodermatitis).

Ma ke alo o ka olelo mai pathological kumu i hoʻohana i loko o ka hana maikaʻi i ka lāʻau ' "Phosphogliv". Na Ke Kumu no ka hoʻohana hoike i kūikawā papa inoa o nā contraindications, i waena i ka papa kuhikuhiE poʻe i hāpai keiki, a lactation. Eia hou kekahi, ia mea pono e hoʻokokoke me ka lōʻihi mālama nui i ke koho ana o ka Agena i loko o nā mea maʻi me ka puka hypertension.

ʻaoʻao 'ole ana kākaʻikahi a uaʻano nui na poe e dermatologic hoikeana (poʻe noʻonoʻoʻole, ka ohane, etc.).

lāʻau "Phosphogliv" Ua häʻawi mai i loko o ka wa e kaawale aku o contraindications i ka hoʻohana 'ana, a, o ka papa, inā loaʻa kekahi kumu nāʻikepili. Na Ke Kumu no ka hoʻohana ana i olelo mai lāʻau Holiday ma ke kuhikuhi wale nō, i nā mea maʻi i malama mai kuokoa a me ka pinepine hoʻokali kūpono 'ana o ka lapaʻauʻia me ke kuhikuhi.

Potent hepatoprotective Stabilizer membranes o ke akepaa keena, e like me ka hoʻokō antiviral lāʻau "Phosphogliv forte", ke aʻo ia i ka palapala noi i kūkākūkā i ka au mamuli luna, ua hoʻohana 'loa pinepine i keia la a me ka pono Makuakane me na hana. Mawaena o na analogues o ka lāʻau ke hoomaopopo "Liv 52" a me ka "Essentiale".